Sitagliptin (MK0431) Inhibition of Dipeptidyl Peptidase IV Decreases Nonobese Diabetic Mouse CD4(+) T-Cell Migration Through Incretin-Dependent and -Independent Pathways

類似資料

• Dipeptidyl Peptidase IV Inhibition With MK0431 Improves Islet Graft Survival in Diabetic NOD Mice Partially via T-Cell Modulation
  著者:: Kim, Su-Jin, 等
  出版事項: (2009)
• Effects of Dipeptidyl Peptidase-4 Inhibition with MK-0431 on Syngeneic Mouse Islet Transplantation
  著者:: Juang, Jyuhn-Huarng, 等
  出版事項: (2014)
• Nature of action of Sitagliptin, the dipeptidyl peptidase-IV inhibitor in diabetic animals
  著者:: Davis, Joseph A., 等
  出版事項: (2010)
• Hypertension and Type 2 Diabetes Are Associated With Decreased Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin
  著者:: Wilson, Jessica R., 等
  出版事項: (2017)
• Letter to the Editor: “Hypertension and Type 2 Diabetes Are Associated With Decreased Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin”
  著者:: Taylor, Simeon I
  出版事項: (2020)